Le Lézard

News by subject: TRI

1 2 3 4 5 6 7 8 9 10

Today

22:00
The CRA Trainer: An Interactive Companion to The CRA's Guide to Monitoring Clinical Research CenterWatch eLearning https://www.centerwatch.com/products//439-the-cra-trainer For 15 years, The CRA's Guide to Monitoring Clinical Research has helped CRAs...

16:05
CTI BioPharma Corp. today announced that following a recent Pre-NDA meeting with the U.S. Food and Drug Administration ("FDA" or "the Agency"), the Company has reached an agreement to submit an NDA for the potential accelerated approval of...

11:15
A petition calling on the UK government to prepare a Challenge Study Center capable of housing 100-200 volunteers for a potential COVID-19 human challenge trial has gained the support of prominent British intellectuals including Lord Ara Darzi, Nobel...

10:18
FlowMetric Life Sciences, Inc., a global leader in immunology testing services, and the Huck Institutes of the Life Sciences at Penn State University announce the creation of a long-term collaboration study assessing the impact on the Centre County...

10:17
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that a Data Monitoring Committee (DMC) meeting was held to review the...

10:00
Researchers have published findings in the journal Nature Scientific Reports that validate the company Genomic Prediction's method for predicting future health risks based on genomic analysis. The study has profound implications for the in vitro...

10:00
Patients with systemic lupus erythematosus (SLE) have a 27% higher risk of having a nonfatal cardiovascular disease (CVD) event compared to age- and sex-matched diabetes mellitus (DM) patients and more than twice the risk of the Medicaid general...

09:30
Optinose , a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the peer-review publication of a paper titled, "Efficacy of the exhalation delivery system with fluticasone...

09:30
A one-two punch of changing gene expression, then deploying immune checkpoint inhibitors, shows promise in battling one of the most treatment-resistant types of cancer in preclinical models, according to a new publication including authors from the...

09:18
iotaMotion, Inc., an early-stage medical technology startup, announced the successful completion of the world's first two robotics-assisted cochlear implant insertions under an Abbreviated Investigational Device Exemption (IDE) using its iotaSOFT...

09:00
Seed Health, a microbial sciences company, today announced U.S. Food and Drug Administration (FDA) authorization of its Investigational New Drug (IND) application for DS-01tm, a broad spectrum multi-species, multi-strain probiotic. The regulatory...

09:00
Aphex BioCleanse Systems, Inc.  ("Aphex" or "the Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products, announced today that it is celebrating the...

08:30
A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Exploring the potential use of NOL monitoring to help enhance recovery after surgery, the...

08:30
entrinsic bioscience (EBS), a company pioneering a next generation protein modulation technology, today announced the initiation of a clinical hydration trial at the renowned United Kingdom's Loughborough University to demonstrate the superiority of...

08:30
Field Trip Psychedelics Inc. ("Field Trip"), the company redefining mental health and well-being through its ground-breaking work in psychedelics and psychedelic-enhanced psychotherapy, has successfully completed GLP (Good Laboratory Practices)...

08:15
-- Creative Medical Technology Holdings announced today proof of concept studies demonstrating efficacy of its ImmCelz® immunotherapy product in the collage induced model of rheumatoid arthritis.  The studies, which involved exposing mouse immune...

08:00
Royal Biologics, an ortho-biologics company specializing in the research and advancement of novel ortho-biologics solutions, today announced the 100th successful implantation of Cryo-Cordtm, cryopreserved placental umbilical cord. They also announced...

08:00
People all over the world are under a raft of added stresses linked to climate, COVID, and crashing economies. The recently published 2020 Social Progress Index notes an alarming and widening discrepancy impacting all Americans, especially people who...

08:00
Scott Sigman, M.D., today announced the publication of a second case report demonstrating positive outcomes for a COVID-19 patient treated with laser therapy. Published in the Canadian Journal of Respiratory Therapy, the article describes a...

07:30
Moleculin Biotech, Inc., (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting significant unmet needs in the treatment of tumors and viruses, announced that its research team has...

07:30
Windtree Therapeutics, Inc. , a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that United States Food and Drug Administration (FDA)...

06:34
More than one hundred doctors and medical workers from Maimonides Medical Center, one of the leading U.S. hospitals at the forefront of the fight against the COVID-19 pandemic since March 2020, expressed strong interest in Russia's Sputnik V vaccine...

04:13
IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced the presentation of clinical research at the 18th Annual Meeting of the Neurocritical Care Society...

03:30
A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Exploring the potential use of NOL monitoring to help enhance recovery after surgery, the...

03:06
Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced positive results from the verification study and will now commence the validation study, the last...

03:05
Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and...

03:00
Daewoong Pharmaceutical (Daewoong) (CEO Sengho Jeon) announced the result of its phase 2 trial on enavogliflozin, a novel SGLT2 inhibitor, for the first time at the 2020 International Congress of Diabetes and...

03:00
Cristal Therapeutics, a Dutch phase 2...

02:00
A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that it is possible to identify healthy individuals with higher risk of cancer based on a simple blood draw....


28 september 2020

16:01
Neurocrine Biosciences, Inc. today announced it will present data analyses evaluating the efficacy and safety of ONGENTYS® (opicapone) capsules, recently approved by the U.S. Food and Drug Administration (FDA) as the first and only once-daily...

13:32
The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, announces the delivery of the first batch of the Russian vaccine against coronavirus, Sputnik V, to the Republic of Belarus. The Sputnik V vaccine is based on a human...

11:00
Researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have identified a cellular pathway that can be targeted with a naturally occurring drug to stimulate lung tissue...

10:25
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today welcomed the news from Nocion Therapeutics, Inc., a...

09:30
Therapeutics Solutions International, Inc., , reported today positive preclinical data demonstrating superior neuro-regenerative activity to other cell therapies such as mesenchymal stem cells.  Using animal models, Company collaborators demonstrated...

09:28
A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that it is possible to identify healthy individuals with higher risk of cancer based on a simple blood draw....

08:35
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Hodgkin Lymphoma. Hodgkin lymphoma is one of the most curable forms of pediatric...

08:10
CSL Behring, a global biotherapeutics leader, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) for routine prophylaxis to prevent...

08:00
Daewoong Pharmaceutical...

08:00
Eiger BioPharmaceuticals, Inc. , focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced results of an investigator sponsored study of Peginterferon Lambda-1a (Lambda) in...

07:30
COVAXX announced today the first healthy adult volunteers were safely dosed in the company's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan. The study is partly supported by a grant from the Ministry...

07:00
On September 25, 2020, BIORAY LABORATORIES Inc. ("Bioraylab"), a company specialized in gene therapy and cell drug R&D, announced for the first time that clinical trials of non-viral PD1 specific targeted CAR T therapy in relapsed/refractory B-cell...

07:00
INOVIO , a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has notified the company it...

06:30
Immunic, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the results of a pre-planned interim safety...

06:00
Stemedica Cell Technologies, Inc. has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) approval for "A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and...

03:25
Sosei Group Corporation ("the Company") (TSE: 4565) has been notified by Pfizer that the first subject in a clinical trial has been dosed with a new drug candidate nominated from the multi-target drug discovery collaboration between the two...

02:51
On July 20 Enzymatica announced the preliminary results from the in vitro study, showing that the mouth spray ColdZyme® deactivates SARS-CoV-2, the virus causing the COVID-19 pandemic. The results of the study, which also includes the common cold...

01:00
PTC Therapeutics, Inc. today announced that two-year data from Part 1 of the FIREFISH study demonstrated that infants on Evrysditm (risdiplam) continued to improve and achieve motor milestones. Evrysditm was approved in August for the treatment of...


27 september 2020

22:15
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today...


25 september 2020

08:11
Biovica, active in blood-based cancer diagnostics, today announced that the company has filed a 510(k) submission with the U.S. Food and Drug Administration (FDA). "The 510(k) submission is a major step towards bringing DiviTum®TKa to patients and we...

06:53
Takeda UK Ltd. is pleased to announce that following a review meeting in July 2020, the NHS England Clinical Priorities Advisory Group (CPAG) has provided a positive recommendation for the routine commissioning of VEYVONDI®?(vonicog alfa), the first...

1 2 3 4 5 6 7 8 9 10